Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Magenta Therapeutics, Inc.

NASDAQ: MGTAHealthcare / Biotechnology / USA
19.50-0.2000-1.02%Vol 241 6181Y Perf 36.43%
Mar 26th, 2019 12:36
BID19.30 ASK19.57
Open19.97 Previous Close19.70
Pre-Market- After-Trading-
 - -%  - -%
Target Price
20.00 
Analyst Rating
— — 0.00
Potencial %
1.52 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)653 
Earnings Rating
Price Range Ratio 52wk %
90.44 
Earnings Date
21st Mar 2019

Today's Price Range

19.1521.00

 

52wk Range

5.3121.00

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
61.74%
3 Months
237.91%
6 Months
64.17%
1 Year
36.43%
3 Years
-
5 Years
-

Name / TickerPriceChg.Chg.%
MGTA19.50-0.2000-1.02
AAPL190.431.69000.90
GOOG1 188.46-4.5400-0.38
MSFT117.23-0.4300-0.37
XOM80.670.75000.94
WFC48.480.40000.83
JNJ138.551.94001.42
FB168.151.86001.12
GE9.980.10001.01
JPM98.940.01000.01
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-

Earnings HistoryEstimateReportedSurprise %
Q04 2018--0.50-
Q03 2018-0.46-0.49-6.52
Q02 2018-0.97-3.13-222.68
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume241 618
Shares Outstanding (in ths.)33 467
Trades Count1 241
Dollar Volume4 488 848
Avg. Volume188 093
Avg. Weekly Volume333 117
Avg. Monthly Volume321 154
Avg. Quarterly Volume184 247

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

67%33%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News